Association for Glycogen Storage Disease

REFINE-1, a Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial With ATX-101, an Injectable Drug for Submental Fat Reduction

Derek Jones, Jean Carruthers, John Joseph et al. · Dermatologic Surgery · 2015 · 130 citations

Reduction of unwanted submental fat with <scp>ATX</scp> ‐101 (deoxycholic acid), an adipocytolytic injectable treatment: results from a phase <scp>III</scp> , randomized, placebo‐controlled study

Berthold Rzany, T.W. Griffiths, Patricia Walker et al. · British Journal of Dermatology · 2013 · 120 citations · Full text

ATX-101 for reduction of submental fat: A phase III randomized controlled trial

Shannon Humphrey, Jonathan M. Sykes, Jonathan Kantor et al. · Journal of the American Academy of Dermatology · 2016 · 119 citations · Full text

Efficacy, patient‐reported outcomes and safety profile of <scp>ATX</scp>‐101 (deoxycholic acid), an injectable drug for the reduction of unwanted submental fat: results from a phase <scp>III</scp>, randomized, placebo‐controlled study

Benjamin Ascher, Klaus Hoffmann, Patricia Walker et al. · Journal of the European Academy of Dermatology and Venereology · 2014 · 117 citations · Full text

Efficacy and Safety of OnabotulinumtoxinA for the Treatment of Crows Feet Lines

Alastair Carruthers, Suzanne Bruce, Arlette De Coninck et al. · Dermatologic Surgery · 2014 · 72 citations